| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | diacylglycerol binding | 3.54e-08 | 16 | 9 | 3 | GO:0019992 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 1.28e-07 | 24 | 9 | 3 | GO:0017075 | |
| GeneOntologyMolecularFunction | phorbol ester receptor activity | 1.81e-07 | 2 | 9 | 2 | GO:0001565 | |
| GeneOntologyMolecularFunction | non-kinase phorbol ester receptor activity | 1.81e-07 | 2 | 9 | 2 | GO:0001566 | |
| GeneOntologyMolecularFunction | syntaxin binding | 6.58e-06 | 87 | 9 | 3 | GO:0019905 | |
| GeneOntologyMolecularFunction | SNARE binding | 2.52e-05 | 136 | 9 | 3 | GO:0000149 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.20e-04 | 230 | 9 | 3 | GO:0005516 | |
| GeneOntologyMolecularFunction | phospholipid binding | 1.53e-03 | 548 | 9 | 3 | GO:0005543 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.73e-03 | 749 | 9 | 3 | GO:0005509 | |
| GeneOntologyMolecularFunction | lipid binding | 8.10e-03 | 988 | 9 | 3 | GO:0008289 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 2.30e-10 | 4 | 9 | 3 | GO:0061789 | |
| GeneOntologyBiologicalProcess | presynaptic dense core vesicle exocytosis | 6.88e-09 | 10 | 9 | 3 | GO:0099525 | |
| GeneOntologyBiologicalProcess | neuronal dense core vesicle exocytosis | 1.26e-08 | 12 | 9 | 3 | GO:0099011 | |
| GeneOntologyBiologicalProcess | dense core granule exocytosis | 2.61e-08 | 15 | 9 | 3 | GO:1990504 | |
| GeneOntologyBiologicalProcess | synaptic vesicle docking | 3.89e-08 | 17 | 9 | 3 | GO:0016081 | |
| GeneOntologyBiologicalProcess | calcium ion-regulated exocytosis of neurotransmitter | 1.31e-07 | 25 | 9 | 3 | GO:0048791 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 1.69e-07 | 2 | 9 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | dense core granule localization | 1.87e-07 | 28 | 9 | 3 | GO:0032253 | |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 2.57e-07 | 31 | 9 | 3 | GO:0016082 | |
| GeneOntologyBiologicalProcess | secretory granule localization | 3.41e-07 | 34 | 9 | 3 | GO:0032252 | |
| GeneOntologyBiologicalProcess | vesicle docking involved in exocytosis | 7.54e-07 | 44 | 9 | 3 | GO:0006904 | |
| GeneOntologyBiologicalProcess | vesicle docking | 2.48e-06 | 65 | 9 | 3 | GO:0048278 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic plasticity | 2.54e-06 | 6 | 9 | 2 | GO:0031914 | |
| GeneOntologyBiologicalProcess | calcium-ion regulated exocytosis | 5.00e-06 | 82 | 9 | 3 | GO:0017156 | |
| GeneOntologyBiologicalProcess | organelle localization by membrane tethering | 5.57e-06 | 85 | 9 | 3 | GO:0140056 | |
| GeneOntologyBiologicalProcess | membrane docking | 6.85e-06 | 91 | 9 | 3 | GO:0022406 | |
| GeneOntologyBiologicalProcess | exocytic process | 1.11e-05 | 107 | 9 | 3 | GO:0140029 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle priming | 1.54e-05 | 14 | 9 | 2 | GO:0010807 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 1.78e-05 | 125 | 9 | 3 | GO:0016079 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 2.09e-05 | 132 | 9 | 3 | GO:0035249 | |
| GeneOntologyBiologicalProcess | regulation of short-term neuronal synaptic plasticity | 3.89e-05 | 22 | 9 | 2 | GO:0048172 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 6.70e-05 | 195 | 9 | 3 | GO:0007269 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 6.70e-05 | 195 | 9 | 3 | GO:0099643 | |
| GeneOntologyBiologicalProcess | innervation | 9.43e-05 | 34 | 9 | 2 | GO:0060384 | |
| GeneOntologyBiologicalProcess | establishment of vesicle localization | 1.01e-04 | 224 | 9 | 3 | GO:0051650 | |
| GeneOntologyBiologicalProcess | vesicle localization | 1.35e-04 | 247 | 9 | 3 | GO:0051648 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 1.55e-04 | 259 | 9 | 3 | GO:0006836 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 1.64e-04 | 264 | 9 | 3 | GO:0099504 | |
| GeneOntologyBiologicalProcess | regulated exocytosis | 2.19e-04 | 291 | 9 | 3 | GO:0045055 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 2.24e-04 | 293 | 9 | 3 | GO:0048167 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 2.93e-04 | 321 | 9 | 3 | GO:0099003 | |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 3.80e-04 | 68 | 9 | 2 | GO:0007528 | |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 5.65e-04 | 83 | 9 | 2 | GO:0048168 | |
| GeneOntologyBiologicalProcess | exocytosis | 7.07e-04 | 434 | 9 | 3 | GO:0006887 | |
| GeneOntologyBiologicalProcess | nerve development | 9.72e-04 | 109 | 9 | 2 | GO:0021675 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 1.14e-03 | 118 | 9 | 2 | GO:0046928 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | 1.38e-03 | 546 | 9 | 3 | GO:0051656 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 1.62e-03 | 141 | 9 | 2 | GO:0051588 | |
| GeneOntologyBiologicalProcess | signal release | 2.30e-03 | 653 | 9 | 3 | GO:0023061 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 2.40e-03 | 663 | 9 | 3 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 2.41e-03 | 664 | 9 | 3 | GO:0099177 | |
| GeneOntologyBiologicalProcess | organelle localization | 2.84e-03 | 703 | 9 | 3 | GO:0051640 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 6.27e-03 | 931 | 9 | 3 | GO:0007268 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 6.27e-03 | 931 | 9 | 3 | GO:0098916 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 6.43e-03 | 939 | 9 | 3 | GO:0099537 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 7.16e-03 | 976 | 9 | 3 | GO:0099536 | |
| GeneOntologyBiologicalProcess | secretion by cell | 9.10e-03 | 1064 | 9 | 3 | GO:0032940 | |
| GeneOntologyBiologicalProcess | export from cell | 1.13e-02 | 1153 | 9 | 3 | GO:0140352 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | 1.26e-02 | 404 | 9 | 2 | GO:1903532 | |
| GeneOntologyBiologicalProcess | secretion | 1.33e-02 | 1221 | 9 | 3 | GO:0046903 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 9.73e-08 | 23 | 9 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | calyx of Held | 3.91e-07 | 36 | 9 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | cell cortex region | 7.76e-07 | 45 | 9 | 3 | GO:0099738 | |
| GeneOntologyCellularComponent | terminal bouton | 7.73e-06 | 96 | 9 | 3 | GO:0043195 | |
| GeneOntologyCellularComponent | neuromuscular junction | 1.23e-05 | 112 | 9 | 3 | GO:0031594 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.45e-05 | 141 | 9 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 4.99e-05 | 179 | 9 | 3 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 4.99e-05 | 179 | 9 | 3 | GO:0030672 | |
| GeneOntologyCellularComponent | axon terminus | 8.03e-05 | 210 | 9 | 3 | GO:0043679 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.09e-04 | 233 | 9 | 3 | GO:0044306 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.82e-04 | 277 | 9 | 3 | GO:0042734 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 2.15e-04 | 293 | 9 | 3 | GO:0030658 | |
| GeneOntologyCellularComponent | synaptic vesicle | 2.31e-04 | 300 | 9 | 3 | GO:0008021 | |
| GeneOntologyCellularComponent | exocytic vesicle | 2.79e-04 | 320 | 9 | 3 | GO:0070382 | |
| GeneOntologyCellularComponent | cytoplasmic region | 3.94e-04 | 360 | 9 | 3 | GO:0099568 | |
| GeneOntologyCellularComponent | cell cortex | 4.30e-04 | 371 | 9 | 3 | GO:0005938 | |
| GeneOntologyCellularComponent | distal axon | 6.85e-04 | 435 | 9 | 3 | GO:0150034 | |
| GeneOntologyCellularComponent | excitatory synapse | 9.13e-04 | 107 | 9 | 2 | GO:0060076 | |
| GeneOntologyCellularComponent | transport vesicle | 1.14e-03 | 519 | 9 | 3 | GO:0030133 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.60e-03 | 583 | 9 | 3 | GO:0097060 | |
| GeneOntologyCellularComponent | presynapse | 5.26e-03 | 886 | 9 | 3 | GO:0098793 | |
| GeneOntologyCellularComponent | axon | 5.34e-03 | 891 | 9 | 3 | GO:0030424 | |
| GeneOntologyCellularComponent | secretory vesicle | 1.35e-02 | 1246 | 9 | 3 | GO:0099503 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 1.54e-02 | 1307 | 9 | 3 | GO:0030659 | |
| GeneOntologyCellularComponent | vesicle membrane | 1.60e-02 | 1325 | 9 | 3 | GO:0012506 | |
| Domain | Unc-13 | 7.74e-11 | 3 | 9 | 3 | IPR027080 | |
| Domain | MHD2 | 7.73e-10 | 5 | 9 | 3 | PS51259 | |
| Domain | Munc13_dom-2 | 7.73e-10 | 5 | 9 | 3 | IPR014772 | |
| Domain | Munc13_subgr_dom-2 | 7.73e-10 | 5 | 9 | 3 | IPR019558 | |
| Domain | DUF1041 | 7.73e-10 | 5 | 9 | 3 | SM01145 | |
| Domain | Membr_traf_MHD | 7.73e-10 | 5 | 9 | 3 | PF10540 | |
| Domain | DUF1041 | 2.71e-09 | 7 | 9 | 3 | PF06292 | |
| Domain | MHD1 | 2.71e-09 | 7 | 9 | 3 | PS51258 | |
| Domain | Munc13_1 | 2.71e-09 | 7 | 9 | 3 | IPR014770 | |
| Domain | CAPS_dom | 2.71e-09 | 7 | 9 | 3 | IPR010439 | |
| Domain | C1_1 | 2.23e-06 | 57 | 9 | 3 | PF00130 | |
| Domain | ZF_DAG_PE_2 | 3.18e-06 | 64 | 9 | 3 | PS50081 | |
| Domain | ZF_DAG_PE_1 | 3.18e-06 | 64 | 9 | 3 | PS00479 | |
| Domain | C1 | 3.33e-06 | 65 | 9 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 3.49e-06 | 66 | 9 | 3 | IPR002219 | |
| Domain | C2 | 2.75e-05 | 131 | 9 | 3 | PF00168 | |
| Domain | C2 | 3.14e-05 | 137 | 9 | 3 | SM00239 | |
| Domain | C2 | 3.50e-05 | 142 | 9 | 3 | PS50004 | |
| Domain | - | 3.96e-05 | 148 | 9 | 3 | 2.60.40.150 | |
| Domain | C2_dom | 5.37e-05 | 164 | 9 | 3 | IPR000008 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 2.47e-06 | 51 | 8 | 3 | M39457 | |
| Pathway | WP_16P112_PROXIMAL_DELETION_SYNDROME | 7.86e-04 | 76 | 8 | 2 | M40057 | |
| Pubmed | 1.20e-11 | 3 | 9 | 3 | 22966208 | ||
| Pubmed | 1.20e-11 | 3 | 9 | 3 | 33105896 | ||
| Pubmed | 1.20e-11 | 3 | 9 | 3 | 15988013 | ||
| Pubmed | 1.20e-11 | 3 | 9 | 3 | 23658173 | ||
| Pubmed | Identification of a Munc13-sensitive step in chromaffin cell large dense-core vesicle exocytosis. | 1.20e-10 | 5 | 9 | 3 | 26575293 | |
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | 1.20e-10 | 5 | 9 | 3 | 34706221 | |
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 4.19e-10 | 7 | 9 | 3 | 36398873 | |
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 6.71e-10 | 8 | 9 | 3 | 25609709 | |
| Pubmed | Molecular and functional architecture of striatal dopamine release sites. | 1.97e-09 | 11 | 9 | 3 | 34767769 | |
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 3.11e-08 | 26 | 9 | 3 | 17124501 | |
| Pubmed | 5.37e-08 | 31 | 9 | 3 | 15217342 | ||
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 5.95e-08 | 2 | 9 | 2 | 28489077 | |
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 5.95e-08 | 2 | 9 | 2 | 31851910 | |
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 5.95e-08 | 2 | 9 | 2 | 19558619 | |
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 12871971 | ||
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 18701688 | ||
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 5.95e-08 | 2 | 9 | 2 | 23229896 | |
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 5.95e-08 | 2 | 9 | 2 | 32187536 | |
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 5.95e-08 | 2 | 9 | 2 | 17267576 | |
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 35613050 | ||
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 12070347 | ||
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 17561838 | ||
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 11792326 | ||
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 5.95e-08 | 2 | 9 | 2 | 11832228 | |
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 22814762 | ||
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 23770256 | ||
| Pubmed | Munc13-independent vesicle priming at mouse photoreceptor ribbon synapses. | 5.95e-08 | 2 | 9 | 2 | 22674279 | |
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 23070049 | ||
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 5.95e-08 | 2 | 9 | 2 | 28772123 | |
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 5.95e-08 | 2 | 9 | 2 | 28426965 | |
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 5.95e-08 | 2 | 9 | 2 | 10440375 | |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 5.95e-08 | 2 | 9 | 2 | 22066784 | |
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 5.95e-08 | 2 | 9 | 2 | 30816091 | |
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 17639022 | ||
| Pubmed | Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming. | 1.79e-07 | 3 | 9 | 2 | 37343100 | |
| Pubmed | Transient, phorbol ester-induced DOC2-Munc13 interactions in vivo. | 3.57e-07 | 4 | 9 | 2 | 10488064 | |
| Pubmed | Fbxo45, a novel ubiquitin ligase, regulates synaptic activity. | 3.57e-07 | 4 | 9 | 2 | 19996097 | |
| Pubmed | Munc13-1-mediated vesicle priming contributes to secretory amyloid precursor protein processing. | 3.57e-07 | 4 | 9 | 2 | 15123597 | |
| Pubmed | ELKS1 localizes the synaptic vesicle priming protein bMunc13-2 to a specific subset of active zones. | 3.57e-07 | 4 | 9 | 2 | 28264913 | |
| Pubmed | 5.95e-07 | 5 | 9 | 2 | 22248876 | ||
| Pubmed | 5.95e-07 | 5 | 9 | 2 | 32755572 | ||
| Pubmed | Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission. | 5.95e-07 | 5 | 9 | 2 | 33139401 | |
| Pubmed | Munc13-1 and Munc18-1 together prevent NSF-dependent de-priming of synaptic vesicles. | 8.92e-07 | 6 | 9 | 2 | 28635948 | |
| Pubmed | 1.25e-06 | 7 | 9 | 2 | 15893389 | ||
| Pubmed | SNARE protein recycling by αSNAP and βSNAP supports synaptic vesicle priming. | 2.68e-06 | 10 | 9 | 2 | 21040848 | |
| Pubmed | The morphological and molecular nature of synaptic vesicle priming at presynaptic active zones. | 3.27e-06 | 11 | 9 | 2 | 25374362 | |
| Interaction | UNC13C interactions | 1.17e-05 | 12 | 9 | 2 | int:UNC13C | |
| Interaction | DIRAS1 interactions | 7.66e-05 | 30 | 9 | 2 | int:DIRAS1 | |
| Interaction | UBXN10 interactions | 1.51e-04 | 42 | 9 | 2 | int:UBXN10 | |
| Interaction | UNC13B interactions | 2.32e-04 | 52 | 9 | 2 | int:UNC13B | |
| GeneFamily | UNC13 homologs | 1.42e-10 | 4 | 7 | 3 | 836 | |
| Coexpression | DESCARTES_MAIN_FETAL_GRANULE_NEURONS | 2.41e-05 | 22 | 9 | 2 | M40087 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.01e-06 | 150 | 9 | 3 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-2|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.89e-04 | 104 | 9 | 2 | 57d2a707aacaa90f92895b87f4ecf87b7451d667 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.59e-04 | 122 | 9 | 2 | a4220adb4e6055a599bd9bbf65d460fc4e68b543 | |
| ToppCell | VE-CD4-CD8_1|VE / Condition, Cell_class and T cell subcluster | 2.64e-04 | 123 | 9 | 2 | bc0f509716bb71d6e3fa343f4920ecb80eb62794 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.22e-04 | 136 | 9 | 2 | b4a934feea46eeb10d407d1545bd225173078792 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-04 | 137 | 9 | 2 | 885e4cfc237eca1fa2eb1f2fd8d84f151e21ecfa | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-04 | 139 | 9 | 2 | ecc2a6ecc27748c50885cd4f0ad8a8cd1252aee6 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-immature_natural_killer_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.71e-04 | 146 | 9 | 2 | 40fac8a298152ec7f7eeeed5a2d28541aea3b338 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.81e-04 | 148 | 9 | 2 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.86e-04 | 149 | 9 | 2 | 558a441804dbcd5b5f39a3b1933b48976711ff15 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor | 3.91e-04 | 150 | 9 | 2 | b0b6ba3686d3eb8a9b249d30be14111de3b893be | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.91e-04 | 150 | 9 | 2 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8-Trm_gut_CD8|bone_marrow / Manually curated celltypes from each tissue | 3.97e-04 | 151 | 9 | 2 | 5eebdc7ad6af3cc0263e4d8c3516818305ac38f2 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.29e-04 | 157 | 9 | 2 | a93866f051472506f1468f379c0d5313e02c9731 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 158 | 9 | 2 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 158 | 9 | 2 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 160 | 9 | 2 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 160 | 9 | 2 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 160 | 9 | 2 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 4.62e-04 | 163 | 9 | 2 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.68e-04 | 164 | 9 | 2 | 84a1808bc6f501218ac2a5a05eb188a07ccd3890 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.73e-04 | 165 | 9 | 2 | cdc05f4a3c2c301f537ae641314875e5ecc16510 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.73e-04 | 165 | 9 | 2 | 567c9f8fe29b5d34c2e39d9a17db54eba51ee559 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.73e-04 | 165 | 9 | 2 | 2ebabe6fdbcf8765bcf9d98faf20da783c9d113d | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.85e-04 | 167 | 9 | 2 | e242827999caad08b0894d88ab97bc1df41b7650 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.02e-04 | 170 | 9 | 2 | 6c65ddb496030bb479ef346cc37a9d4dfa6b824f | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.08e-04 | 171 | 9 | 2 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.32e-04 | 175 | 9 | 2 | f2c3e0f728a43d6988e793c8a50c964f7447db82 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.32e-04 | 175 | 9 | 2 | 06eace2e681980456299167b48bd49bcfea5e940 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.38e-04 | 176 | 9 | 2 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.38e-04 | 176 | 9 | 2 | da5933eb253f13e70296a50a2bb00ad5c19a2d99 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.44e-04 | 177 | 9 | 2 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.50e-04 | 178 | 9 | 2 | f94e306b9550f3d1b5de0bb806790c17823d439e | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.63e-04 | 180 | 9 | 2 | 310a311c3ed924c912a800cf287a825de44b8775 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 181 | 9 | 2 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 5.88e-04 | 184 | 9 | 2 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 5.94e-04 | 185 | 9 | 2 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.94e-04 | 185 | 9 | 2 | f1263899a2d41d182022dc4ca62cbae08a463c89 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.00e-04 | 186 | 9 | 2 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.13e-04 | 188 | 9 | 2 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.20e-04 | 189 | 9 | 2 | d05e043d0874b8563b9f5514f6c884b35c603e3a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.26e-04 | 190 | 9 | 2 | be2b184a3559da41ba387ae0fdbeb9ae532868a5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.26e-04 | 190 | 9 | 2 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.26e-04 | 190 | 9 | 2 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.39e-04 | 192 | 9 | 2 | 342842378c20267c5044bdd622515e8b9f895623 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.53e-04 | 194 | 9 | 2 | d024cd75a97f048257e49cee9190fb2e79202ee2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.59e-04 | 195 | 9 | 2 | a4d36654b968acb1aea252ac203683939461f1d1 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.59e-04 | 195 | 9 | 2 | 4b9663509cc5e3f409f6d0d37640cb301a827d98 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.59e-04 | 195 | 9 | 2 | cd811abd949ef201aef1c8515da5575ab1b1cfea | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.59e-04 | 195 | 9 | 2 | e06ff785c5542c86c335d956799e03f7ae8345a4 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.59e-04 | 195 | 9 | 2 | d70b49f6b9c6c4422adb2936c837a1af7569fb0a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.59e-04 | 195 | 9 | 2 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.59e-04 | 195 | 9 | 2 | 36c784709ee32174e05b457500339c3b8eee3244 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.66e-04 | 196 | 9 | 2 | 1cc2b11764584129703ec61965e8ec4e051464e7 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.66e-04 | 196 | 9 | 2 | c9fb81a0578db6d278b8582d7b3add6c407e6dcf | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.66e-04 | 196 | 9 | 2 | 0175b097ad1338a07afebe3b5c7fd0bb0bb950f7 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.66e-04 | 196 | 9 | 2 | fd756b247b2d8a291e8e71bec6f1e463d6557536 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-gd_T|ICU-SEP / Disease, condition lineage and cell class | 6.80e-04 | 198 | 9 | 2 | b40899f8f5f32420fb4574069dd7afd9e7e70d91 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.87e-04 | 199 | 9 | 2 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| Disease | epilepsy (implicated_via_orthology) | 1.36e-05 | 163 | 9 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.32e-05 | 195 | 9 | 3 | DOID:1574 (implicated_via_orthology) | |
| Disease | human papilloma virus infection, oropharynx cancer | 1.13e-04 | 53 | 9 | 2 | EFO_0001668, EFO_1001931 | |
| Disease | urinary albumin to creatinine ratio | 1.28e-03 | 179 | 9 | 2 | EFO_0007778 | |
| Disease | neuropsychological test | 1.55e-03 | 197 | 9 | 2 | EFO_0003926 | |
| Disease | obsolete aging | 3.07e-03 | 279 | 9 | 2 | GO_0007568 | |
| Disease | executive function measurement | 5.50e-03 | 376 | 9 | 2 | EFO_0009332 | |
| Disease | memory performance | 6.47e-03 | 409 | 9 | 2 | EFO_0004874 | |
| Disease | age at menarche | 1.33e-02 | 594 | 9 | 2 | EFO_0004703 | |
| Disease | amino acid measurement | 1.71e-02 | 678 | 9 | 2 | EFO_0005134 | |
| Disease | Colorectal Carcinoma | 1.82e-02 | 702 | 9 | 2 | C0009402 | |
| Disease | asthma | 2.07e-02 | 751 | 9 | 2 | MONDO_0004979 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FEVWTATTPTYCYEC | 556 | Q9UPW8 | |
| ATTPTYCYECEGLLW | 561 | Q9UPW8 | |
| CEPYTTWCQETYSQT | 71 | Q9BUR5 | |
| CSITTETFYPTLWCF | 56 | Q96SE0 | |
| YWYCPSCKTDSSEVV | 386 | Q96PU4 | |
| EVWTATTPTYCYECE | 1101 | Q8NB66 | |
| EVWTATTPTYCYECE | 481 | O14795 | |
| VPCYSECNQYSWVVE | 1051 | Q9C0I4 | |
| YSECEDGTYSPEISW | 416 | P48651 | |
| SVYSEYCSTEIRWIC | 196 | Q12918 |